Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group

To determine if the time-to-chemotherapy (TTC) after primary macroscopic complete cytoreductive surgery (CRS) influences recurrence-free survival (RFS) and overall survival (OS) in patients with epithelial ovarian cancer (EOC). We conducted an observational multicenter retrospective cohort analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Rocher, Grégoire, Gaillard, Thomas, Uzan, Catherine, Collinet, Pierre, Bolze, Pierre-Adrien, Ballester, Marcos, Bendifallah, Sofiane, Ouldamer, Lobna, Touboul, Cyril, Huchon, Cyrille, Lavoue, Vincent, Dabi, Yohann, Akladios, Cherif, Coutant, Charles, Raimond, Emilie, Bricou, Alexandre, Canlorbe, Geoffroy, Azaïs, Henri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961531/
https://www.ncbi.nlm.nih.gov/pubmed/33806443
http://dx.doi.org/10.3390/jcm10051058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961531/
https://www.ncbi.nlm.nih.gov/pubmed/33806443
http://dx.doi.org/10.3390/jcm10051058

Ejemplares similares